David Michael Miller, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Merkel Cell | 7 | 2022 | 329 | 3.110 |
Why?
|
Skin Neoplasms | 20 | 2022 | 5864 | 2.490 |
Why?
|
Neoplasms, Basal Cell | 2 | 2022 | 30 | 0.990 |
Why?
|
Melanoma | 9 | 2019 | 5709 | 0.740 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2830 | 0.740 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2022 | 4064 | 0.700 |
Why?
|
Ulcer | 1 | 2021 | 203 | 0.680 |
Why?
|
Biological Products | 2 | 2020 | 947 | 0.680 |
Why?
|
Drug Approval | 3 | 2022 | 821 | 0.650 |
Why?
|
Lymphoma, Primary Cutaneous Anaplastic Large Cell | 1 | 2018 | 8 | 0.640 |
Why?
|
Transplantation Tolerance | 3 | 2008 | 633 | 0.630 |
Why?
|
Kaposi Varicelliform Eruption | 1 | 2018 | 47 | 0.610 |
Why?
|
Immunotherapy | 6 | 2022 | 4756 | 0.600 |
Why?
|
Chimerism | 2 | 2009 | 156 | 0.590 |
Why?
|
Toll-Like Receptors | 3 | 2009 | 582 | 0.550 |
Why?
|
Carcinoma, Basal Cell | 1 | 2022 | 565 | 0.540 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2018 | 664 | 0.460 |
Why?
|
Psoriasis | 1 | 2020 | 926 | 0.390 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2017 | 2059 | 0.360 |
Why?
|
Lymphocyte Activation | 3 | 2009 | 5505 | 0.330 |
Why?
|
Medical Oncology | 1 | 2021 | 2350 | 0.310 |
Why?
|
United States Food and Drug Administration | 3 | 2022 | 1672 | 0.310 |
Why?
|
Antineoplastic Agents | 3 | 2022 | 13698 | 0.270 |
Why?
|
Isoantigens | 1 | 2009 | 562 | 0.270 |
Why?
|
Tumor Burden | 2 | 2021 | 1913 | 0.240 |
Why?
|
Protein Kinase Inhibitors | 4 | 2019 | 5707 | 0.230 |
Why?
|
Lipopolysaccharides | 2 | 2009 | 2222 | 0.230 |
Why?
|
Oncolytic Virotherapy | 2 | 2020 | 521 | 0.220 |
Why?
|
Neoplasm Staging | 4 | 2022 | 11262 | 0.210 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10400 | 0.210 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3608 | 0.190 |
Why?
|
Virus Diseases | 1 | 2008 | 724 | 0.190 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2021 | 95 | 0.180 |
Why?
|
Interdisciplinary Studies | 1 | 2021 | 86 | 0.180 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2020 | 64 | 0.180 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2909 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2016 | 1246 | 0.170 |
Why?
|
Retreatment | 1 | 2021 | 600 | 0.170 |
Why?
|
Immunologic Factors | 2 | 2022 | 1597 | 0.160 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2010 | 89 | 0.160 |
Why?
|
Lichen Planus | 1 | 2020 | 70 | 0.160 |
Why?
|
Microphthalmia-Associated Transcription Factor | 2 | 2018 | 257 | 0.160 |
Why?
|
Poly I-C | 2 | 2009 | 111 | 0.160 |
Why?
|
Skin Transplantation | 3 | 2009 | 1097 | 0.160 |
Why?
|
Immunity, Innate | 2 | 2008 | 3080 | 0.160 |
Why?
|
Receptor, Interferon alpha-beta | 2 | 2009 | 113 | 0.150 |
Why?
|
Polyomavirus Infections | 1 | 2020 | 192 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 329 | 0.150 |
Why?
|
Humans | 31 | 2022 | 768970 | 0.140 |
Why?
|
Ultraviolet Rays | 1 | 2022 | 1104 | 0.140 |
Why?
|
Oncolytic Viruses | 1 | 2020 | 345 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2019 | 637 | 0.130 |
Why?
|
Workflow | 1 | 2021 | 859 | 0.130 |
Why?
|
Immunosuppressive Agents | 1 | 2008 | 4207 | 0.130 |
Why?
|
Transplantation Immunology | 2 | 2008 | 537 | 0.120 |
Why?
|
Neuralgia | 1 | 2021 | 622 | 0.120 |
Why?
|
Transplantation Chimera | 2 | 2008 | 594 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2017 | 725 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2010 | 5716 | 0.110 |
Why?
|
Uveal Neoplasms | 1 | 2017 | 344 | 0.110 |
Why?
|
Herpesvirus 1, Human | 1 | 2018 | 744 | 0.110 |
Why?
|
United States | 4 | 2022 | 73186 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2022 | 11886 | 0.100 |
Why?
|
Serpins | 2 | 2004 | 246 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3671 | 0.090 |
Why?
|
Indoles | 1 | 2019 | 1836 | 0.090 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 719 | 0.090 |
Why?
|
Genes, ras | 1 | 2014 | 665 | 0.090 |
Why?
|
Interferon Type I | 2 | 2019 | 569 | 0.090 |
Why?
|
Enhancer Elements, Genetic | 1 | 2018 | 1369 | 0.090 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4926 | 0.090 |
Why?
|
Retinoblastoma Protein | 1 | 2014 | 673 | 0.090 |
Why?
|
Bone Marrow Transplantation | 2 | 2009 | 2709 | 0.090 |
Why?
|
Interferon-alpha | 1 | 2014 | 910 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2019 | 4651 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2893 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6805 | 0.080 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8559 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.080 |
Why?
|
Toll-Like Receptor 3 | 1 | 2008 | 99 | 0.080 |
Why?
|
Cell Cycle | 1 | 2016 | 2937 | 0.070 |
Why?
|
Massachusetts | 1 | 2021 | 8894 | 0.070 |
Why?
|
Interleukin-2 | 1 | 2014 | 1895 | 0.070 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 2931 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3538 | 0.070 |
Why?
|
Receptors, Pattern Recognition | 1 | 2008 | 81 | 0.070 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 263 | 0.070 |
Why?
|
Signal Transduction | 4 | 2014 | 23653 | 0.070 |
Why?
|
Aged, 80 and over | 3 | 2021 | 59739 | 0.070 |
Why?
|
Radiation Tolerance | 1 | 2008 | 478 | 0.070 |
Why?
|
Histocompatibility Testing | 1 | 2008 | 716 | 0.060 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2008 | 305 | 0.060 |
Why?
|
Mice, Inbred BALB C | 3 | 2010 | 6232 | 0.060 |
Why?
|
Mice | 9 | 2019 | 82072 | 0.060 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 962 | 0.060 |
Why?
|
Animals | 12 | 2019 | 169335 | 0.060 |
Why?
|
Mice, Knockout | 3 | 2010 | 14484 | 0.060 |
Why?
|
Scyphozoa | 1 | 2004 | 10 | 0.060 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 587 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3463 | 0.060 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 582 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5342 | 0.060 |
Why?
|
Graft Rejection | 2 | 2008 | 4492 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 81903 | 0.060 |
Why?
|
Disease Progression | 1 | 2021 | 13674 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6214 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2021 | 65480 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2008 | 4835 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15951 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8664 | 0.050 |
Why?
|
Aged | 4 | 2022 | 171786 | 0.050 |
Why?
|
Graft Survival | 2 | 2009 | 3888 | 0.050 |
Why?
|
Mutation | 2 | 2017 | 30266 | 0.050 |
Why?
|
Prognosis | 1 | 2021 | 30046 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2019 | 3621 | 0.040 |
Why?
|
raf Kinases | 1 | 2019 | 117 | 0.040 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 542 | 0.040 |
Why?
|
Cohort Studies | 1 | 2021 | 41808 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2002 | 752 | 0.040 |
Why?
|
Immune Tolerance | 1 | 2007 | 2323 | 0.040 |
Why?
|
SOXE Transcription Factors | 1 | 2018 | 73 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2007 | 2059 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 8055 | 0.040 |
Why?
|
Phenylenediamines | 1 | 2018 | 89 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2020 | 437 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 1 | 2010 | 3408 | 0.040 |
Why?
|
Metalloproteins | 1 | 2017 | 98 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2002 | 1027 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2017 | 103 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2408 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9565 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2017 | 148 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2008 | 4413 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2017 | 246 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4939 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 190 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2017 | 453 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2019 | 1608 | 0.030 |
Why?
|
Ribosomal Proteins | 1 | 2017 | 370 | 0.030 |
Why?
|
Male | 4 | 2021 | 365203 | 0.030 |
Why?
|
Mice, Inbred NOD | 2 | 2010 | 1839 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27453 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1575 | 0.030 |
Why?
|
Mice, SCID | 2 | 2010 | 2631 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36854 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1105 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 524 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2009 | 22379 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 572 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3629 | 0.030 |
Why?
|
Gene Amplification | 1 | 2018 | 1099 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 17173 | 0.020 |
Why?
|
Telomerase | 1 | 2017 | 753 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 223737 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3631 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1120 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10276 | 0.020 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2010 | 220 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6547 | 0.020 |
Why?
|
Female | 4 | 2021 | 397515 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18354 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8748 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2010 | 699 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4148 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3433 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6131 | 0.020 |
Why?
|
Genetic Loci | 1 | 2018 | 2630 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1891 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4794 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2007 | 438 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2960 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3952 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2007 | 915 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4785 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3048 | 0.020 |
Why?
|
Phylogeny | 2 | 2004 | 2843 | 0.020 |
Why?
|
Protein Denaturation | 1 | 2004 | 242 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3836 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2010 | 2683 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2862 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2008 | 1866 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2122 | 0.010 |
Why?
|
Thymus Gland | 1 | 2008 | 1266 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5804 | 0.010 |
Why?
|
Spleen | 1 | 2008 | 2294 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9527 | 0.010 |
Why?
|
Gene Library | 1 | 2004 | 1062 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13427 | 0.010 |
Why?
|
Cathepsins | 1 | 2002 | 242 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2002 | 1142 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2004 | 17629 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2017 | 7885 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2004 | 2179 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2008 | 2395 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5906 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4168 | 0.010 |
Why?
|
Bone Marrow | 1 | 2008 | 2936 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2749 | 0.010 |
Why?
|
Kinetics | 1 | 2002 | 6332 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2002 | 2001 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2007 | 3116 | 0.010 |
Why?
|